Literature DB >> 30711195

The United States opioid epidemic.

Jennifer Lyden1, Ingrid A Binswanger2.   

Abstract

The United States opioid epidemic is a nationwide public health crisis. Initially driven by increased consumption and availability of pharmaceutical opioids, an increasing number of opioid overdoses are now related to heroin and illicitly manufactured fentanyl and fentanyl analogs. Addressing this epidemic requires addressing the stigma associated with opioid use disorders and its treatment, improving access to efficacious treatment options, specifically methadone and buprenorphine, and reducing opioid overdose fatalities with distribution of the opioid antagonist and overdose reversal agent naloxone.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Opioids; Overdose

Mesh：

Substances：

Year:  2019        PMID： 30711195      PMCID： PMC6578581          DOI： 10.1053/j.semperi.2019.01.001

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN： 0146-0005            Impact factor:   3.300


  95 in total

1.  Preventing and Treating Narcotic Addiction--Century of Federal Drug Control.

Authors:  David T Courtwright
Journal:  N Engl J Med       Date:  2015-11-26       Impact factor: 91.245

2.  Abuse of prescription drugs and the risk of addiction.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2006-03-23       Impact factor: 4.492

3.  Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response.

Authors:  Lauren M Broyles; Ingrid A Binswanger; Jennifer A Jenkins; Deborah S Finnell; Babalola Faseru; Alan Cavaiola; Marianne Pugatch; Adam J Gordon
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

4.  Medications For Addiction Treatment: Changing Language to Improve Care.

Authors:  Sarah E Wakeman
Journal:  J Addict Med       Date:  2017 Jan/Feb       Impact factor: 3.702

5.  Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.

Authors:  M E Hale; R Fleischmann; R Salzman; J Wild; T Iwan; R E Swanton; R F Kaiko; P G Lacouture
Journal:  Clin J Pain       Date:  1999-09       Impact factor: 3.442

6.  Oxycodone and oxycontin.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2001-09-17       Impact factor: 1.909

Review 7.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

8.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

9.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

Review 10.  Review of the assessment and management of neonatal abstinence syndrome.

Authors:  Sarah Mary Bagley; Elisha M Wachman; Erica Holland; Susan B Brogly
Journal:  Addict Sci Clin Pract       Date:  2014-09-09
View more
  40 in total

1.  Opioid Use among Individuals with Traumatic Brain Injury: A Perfect Storm?

Authors:  Rachel Sayko Adams; John D Corrigan; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2019-08-16       Impact factor: 5.269

2.  Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain.

Authors:  Mireia Carcolé; Sami Kummer; Leonor Gonçalves; Daniel Zamanillo; Manuel Merlos; Anthony H Dickenson; Begoña Fernández-Pastor; David Cabañero; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2019-09-12       Impact factor: 8.739

3.  Preoperative duration of pain is associated with chronic opioid use after adult spinal deformity surgery.

Authors:  Kevin C Mo; Rahul Sachdev; Bo Zhang; Amar Vadhera; Mark Ren; Nicholas S Andrade; Khaled M Kebaish; Richard L Skolasky; Brian J Neuman
Journal:  Spine Deform       Date:  2022-06-24

4.  Invited Commentary: Intermittent Opioid Use and Ischemic Placental Disease-Clarifying Associations With Adverse Pregnancy Outcomes.

Authors:  Cande V Ananth; Justin S Brandt
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

5.  Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.

Authors:  Charlan D Kroelinger; Donna Addison; Mirelys Rodriguez; Marion E Rice; Meghan T Frey; Hadley R Hickner; Mary Kate Weber; Trish Mueller; Alisa Velonis; Keriann Uesugi; Lisa Romero; Sanaa Akbarali; Natalie Foster; Jean Y Ko; Ellen Pliska; Christine Mackie; Shanna Cox; S Nicole Fehrenbach; Wanda D Barfield
Journal:  J Womens Health (Larchmt)       Date:  2020-03-13       Impact factor: 2.681

Review 6.  Medications Development for Treatment of Opioid Use Disorder.

Authors:  E Andrew Townsend; S Stevens Negus; Matthew L Banks
Journal:  Cold Spring Harb Perspect Med       Date:  2021-01-04       Impact factor: 6.915

7.  Synthetic efforts toward the bicyclo[3.2.1]octane fragment of rhodojaponin III.

Authors:  Caroline G Webster; Hyeri Park; Amanda F Ennis; Jiyong Hong
Journal:  Tetrahedron Lett       Date:  2021-04-06       Impact factor: 2.415

8.  Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D3 Receptor Antagonists and Partial Agonists.

Authors:  Anver Basha Shaik; Vivek Kumar; Alessandro Bonifazi; Adrian M Guerrero; Sophie L Cemaj; Alexandra Gadiano; Jenny Lam; Zheng-Xiong Xi; Rana Rais; Barbara S Slusher; Amy Hauck Newman
Journal:  J Med Chem       Date:  2019-10-15       Impact factor: 7.446

9.  High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics.

Authors:  Mariana Lemos Duarte; Nikita A Trimbake; Achla Gupta; Christine Tumanut; Xiaomin Fan; Catherine Woods; Akila Ram; Ivone Gomes; Erin N Bobeck; Deborah Schechtman; Lakshmi A Devi
Journal:  Commun Biol       Date:  2021-02-22

10.  Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures.

Authors:  Diana E Clarke; Adila Ibrahim; Benjamin Doty; Sejal Patel; Debbie Gibson; Anna Pagano; Laura Thompson; Amy B Goldstein; Frank Vocci; Robert P Schwartz
Journal:  Subst Abuse Rehabil       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.